buy signal?, page-43

Just to add to the discussion, I think very speculative stocks such as Prima are valued according to their risk profile, as well as their fundamental data ie, risk that trial data will be positive, cash burn risk ( will it increase more than the company has factored in their projections), risks that fda will /won't approve use of CVAC - the market can be quite ruthless in their value of any company - BUT, once they start to prove their projections, the risk value gets removed from the future market of the company, and thus, the market values the company more highly/positively.

And also, generally speaking, the Aussie mkt does not (want to) understand the science behind most of these biotech stocks.

Therefore, if you can be 1 step ahead of the market, and make it your job to understand management, where they are going, and the science behind their products/trials - you will be well rewarded - once the market finally figures it out, you will be MUCH further ahead.

IMHO

Spare paper